Universal Music Enterprises' new platform, Urban Legends launched on November 20th to celebrate the revolutionary and defining recordings primarily of the 1980s, 1990s and 2000s. VP of Urban Catalog at UMe, Andre Torres, sits down with Alyssa Julya Smith in Los Angeles to explain the concept behind the new site. At its core, Urban Legends serves as both an editorial content site and ecommerce platform, delivering daily news, editorial features and franchises, and video updates on hip hop and R&B artists. Torres explains the site will also be a place for fans to purchase vintage and new CDs, vinyl, and cassettes, as well as reissued classic albums as deluxe vinyl box sets to celebrate three decades of music. UMG’s urban catalog music world is also fully available, with Urban Legends highlighting exclusive interviews, product drops, and artist conversations.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More